|
|
14#

樓主 |
發(fā)表于 2022-12-17 20:03:58
|
只看該作者
來自: 中國江蘇泰州

除了相當年輕的勞動力結(jié)構(gòu),卡塔爾疫苗接種全球前十,這是他們開放的重要基礎(chǔ)也是死亡比流感低的重要原因。下面是詳細的疫苗情況,我們拿她的結(jié)論來套,就是邯鄲學步
卡塔爾衛(wèi)生部宣布,有清晰的醫(yī)學證據(jù)表明,在接種批準的疫苗的第二針六個月后,抵抗新冠病毒的免疫系統(tǒng)開始逐漸減弱?ㄋ枮榱舜_保本國人口的安全,特將新冠疫苗的有效期從第二針之后的12個月縮短至9個月。
The Ministry of Public Health announced, that there is clear medical evidence that protective immunity from COVID-19 infection begins to decline six months after the second dose of an approved vaccine. The State of Qatar, in order to ensure the health and safety of the population, has changed the vaccine validity of COVID-19 immunity from 12 months to 9 months following the second dose.
該改動的生效日期是2022年2月1日,也就是說在2022年2月1日之前9個月以上接種了輝瑞,莫得那,阿斯利康第二針的將被認為是未接種疫苗,在健康碼軟件上也就沒有了那個金邊。
The change comes into effect on 1 February 2022 and means that individuals whose second COVID-19 vaccine dose of Pfizer-BioNTech, Moderna or AstraZeneca was more than 9 months ago on 1 February 2022 will be considered unvaccinated and will lose their Gold Frame (immunized) status on Ehteraz.
接種一針加強針可以恢復金邊并保持9個月。這也讓卡塔爾同中東區(qū)域以及國際的做法同規(guī),共同應對當前的全球大流行。
Receiving a booster vaccine dose will reinstate their Gold Frame status for a further 9 months. This aligns Qatar with the protective actions being taken by other countries in the region and the world, to address the ongoing pandemic. |
|